Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Craig E. Gordon"'
Autor:
Abraham Cohen-Bucay, Silvia E. Ramirez-Andrade, Craig E. Gordon, Jean M. Francis, Vipul C. Chitalia
Publikováno v:
Kidney Medicine, Vol 2, Iss 6, Pp 771-786 (2020)
Reactivation of BK virus (BKV) remains a dreaded complication in immunosuppressed states. Conventionally, BKV is known as a cause for BKV-associated nephropathy and allograft dysfunction in kidney transplant recipients. However, emerging studies have
Externí odkaz:
https://doaj.org/article/fe9abad0340a4ecb8d972beaad88bec2
Autor:
Amandeep Godara, Daniel R. Migliozzi, Monika Pilichowska, Nitender Goyal, Cindy Varga, Craig E. Gordon
Publikováno v:
Kidney Medicine, Vol 2, Iss 5, Pp 652-656 (2020)
Transplant-associated thrombotic microangiopathy (TMA) in the post–organ transplantation setting occurs from a number of potential inciting factors, such as the use of calcineurin inhibitors, ischemic injury, infections, or antibody-mediated reject
Externí odkaz:
https://doaj.org/article/49353c1a2d1d4d13aa27ff63c0660a2c
Autor:
Priyamvada Singh, Hui Chen, Craig E. Gordon, Sandeep Ghai, J. Mark Sloan, Karen Quillen, Sara Moradi, Vipul Chitalia, Amitabh Gautam, Joel Henderson, Jean M. Francis
Publikováno v:
Kidney Medicine, Vol 1, Iss 3, Pp 139-143 (2019)
Eculizumab is an emerging therapy for atypical hemolytic uremic syndrome (aHUS). Early identification and treatment of recurrent aHUS after kidney transplantation requires a high clinical suspicion but results in improved graft function and patient o
Externí odkaz:
https://doaj.org/article/731970afc2ed48ad81f00a13e6aeffe2
Autor:
Michel Jadoul, Marina C. Berenguer, Wahid Doss, Fabrizio Fabrizi, Jacques Izopet, Vivekanand Jha, Nassim Kamar, Bertram L. Kasiske, Ching-Lung Lai, Jose´ M. Morales, Priti R. Patel, Stanislas Pol, Marcelo O. Silva, Ethan M. Balk, Craig E. Gordon, Amy Earley, Mengyang Di, Paul Martin
Publikováno v:
Počki, Vol 7, Iss 4, Pp 261-268 (2018)
No abstract
Externí odkaz:
https://doaj.org/article/3cdec82a2f454c6687b2921cafea2d3f
Publikováno v:
F1000Research, Vol 8 (2019)
Kidney transplantation (KT) is the most effective way to decrease the high morbidity and mortality of patients with end-stage renal disease. However, KT does not completely reverse the damage done by years of decreased kidney function and dialysis. F
Externí odkaz:
https://doaj.org/article/cfa152da939d4ee2881149e58d729126
Publikováno v:
Seminars in Nephrology. 42:14-28
Kidney transplantation remains the treatment of choice for patients with end-stage kidney disease. Significant progress has been made over the course of many years to improve both patient and graft outcomes after transplant. Modern immunosuppressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cef01f87eee4bc6ab8640af1e29d0cb5
https://doi.org/10.1016/j.semnephrol.2022.01.006
https://doi.org/10.1016/j.semnephrol.2022.01.006
Publikováno v:
American Journal of Kidney Diseases, (2023)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e0f0ce97dcdd5df38d1ffb7ff84da4f
https://hdl.handle.net/2078.1/272294
https://hdl.handle.net/2078.1/272294
Autor:
Craig E. Gordon, Ronald D. Perrone
Publikováno v:
Advances in Kidney Disease and Health. 30:207-208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66c2be1133b47831c18d082d680d7de1
https://doi.org/10.1053/j.akdh.2023.03.002
https://doi.org/10.1053/j.akdh.2023.03.002
Autor:
Mengyang Di, Marina Berenguer, Michel Jadoul, Wahid Doss, Jacques Izopet, Fabrizio Fabrizi, Stanislas Pol, Amy Earley, Vivekanand Jha, Ethan M Balk, Craig E. Gordon, Priti R. Patel, Paul J. Martin, Ching-Lung Lai, Nassim Kamar, Bertram L. Kasiske, José M. Morales, Marcelo Silva
Publikováno v:
KIDNEYS. 7:261-268
Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy and in those with a kidney transplant. Since the publication of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90dd0a96e46474c8dfb97ef967fd4ea7
https://doi.org/10.22141/2307-1257.7.4.2018.148514
https://doi.org/10.22141/2307-1257.7.4.2018.148514
Autor:
Paul, Martin, Ahmed A, Awan, Marina C, Berenguer, Annette, Bruchfeld, Fabrizio, Fabrizi, David S, Goldberg, Jidong, Jia, Nassim, Kamar, Rosmawati, Mohamed, Mário Guimarães, Pessôa, Stanislas, Pol, Meghan E, Sise, Ethan M, Balk, Craig E, Gordon, Gaelen, Adam, Michael, Cheung, Amy, Earley, Michel, Jadoul
Publikováno v:
Kidney international. 102(6)
Infection with the hepatitis C virus (HCV) has adverse liver, kidney, and cardiovascular consequences in patients with chronic kidney disease (CKD), including those on dialysis therapy or with a kidney transplant. Since the publication of the Kidney
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34d486187137b1320ddd1986f3561718
https://pubmed.ncbi.nlm.nih.gov/36411019
https://pubmed.ncbi.nlm.nih.gov/36411019